UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

5 Dec 2007

Neupro® Filed in Europe for the Treatment of Restless Legs Syndrome

Read More
3 Dec 2007

UCB Announces Positive Phase III Trial Results for Keppra XR(TM)

Read More
29 Nov 2007

UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy

Read More
29 Nov 2007

UCB Announces FDA Filing for lacosamide in the Treatment of Diabetic Neuropathic Pain

Read More
16 Nov 2007

UCB to Appeal European Negative Opinion on CIMZIA® for the Treatment of Patients with Crohn's Disease

Read More
26 Oct 2007

UCB Announces Initiation of Phase III Clinical Program for RikeltaTM (brivaracetam) as Adjunctive Treatment in Partial-Onset Epilepsy

Read More

Stay up-to-date on the latest news and information from UCB